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Abstract  
 
Background 
Postpartum depression is the most common psychopathology encountered in the period  
following childbirth. In addition to increasing the risk of maternal suicide and infanticide,  
it is associated with significant morbidity, adversely affecting the patient, infant and family.  
Despite postpartum depression being an important public health issue it remains poorly 
recognised and underdiagnosed. 
 
The current South African context in which obstetric care is delivered to patients focuses  
predominantly on physical health. No screening policy for postpartum depression is  
currently recommended in South Africa.  
 
The aim of this study was to determine the proportion of patients at risk of postpartum 
depression by screening mothers at six weeks postnatally using the Edinburgh postnatal 
depression scale. 
 
Methods  
Patients delivered by vaginal delivery and caesaerean section at Rahima Moosa Mother and 
Child Hospital were randomly selected from delivery records for recruitment to the study. A 
baseline sociodemographic, medical and obstetric questionnaire was completed at the 
enrolment visit in all patients that consented to participate. Participants were then contacted 
telephonically six weeks later. The Edinburgh postnatal depression scale was sent via text 
message to patients and they were allowed time to respond at their convenience. Participants 
were contacted to retrieve their responses and formulate scores. Screen positive patients were 
identified by a score of thirteen or greater on the Edinburgh postnatal depression scale or a 
positive response to thoughts of self or infant harm and were offered referral to the 
department of psychiatry.  
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Results 
A total of 178 patients were screened for postpartum depression using the Edinburgh 
postnatal depression scale. The main outcome measured was the proportion of screen positive 
participants who exceeded the threshold score on the Edinburgh postnatal depression scale or 
responded positively to thoughts of deliberate self or infant harm. Forty-eight participants 
screened positive resulting in 27.0% of the study population being at risk of postpartum 
depression.  
 
Sociodemographic, medical and obstetric variables were analysed in screen positive compared 
to screen negative participants to establish possible correlations between these variables and 
outcome. None of the variables proved to be significantly associated with being screen 
positive for postpartum depression.  
 
Conclusion 
The results of this study when compared to the prevalence findings of local and international 
studies suggest that postpartum depressive symptomology is common in urban South Africa. 
Since this study did not establish a statistically significant relationship between possible 
predisposing factors and the risk of postpartum depression, no specific variables have been 
implicated in predicting postpartum depression in our study population. These findings 
support the need for universal screening for postpartum depression in South Africa. Further 
research to investigate risk factors for postpartum depression in a South African setting is 
recommended. 
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1. Introduction 
Mood disorders constitute the most common and serious maternal psychiatric conditions  
in the postpartum period.1  The United Kingdom’s confidential enquiries into maternal  
deaths identified mental illness as a major contributor to maternal death by suicide over  
the past two decades.2,3 In addition to increasing the risk of maternal suicide and infanticide,  
postpartum depression (PPD) in particular is associated with significant morbidity.4 The 
impact of depressive symptoms in the critical postpartum period extends beyond poor 
maternal health to adversely affect the infant and family structure at large.4 Despite PPD 
being an important public health concern carrying significant morbidity and  potentially life 
threatening complications, the condition remains poorly recognised and underdiagnosed.4,5  
 
2. Literature Review 
2.1 Perinatal Mental Illness 
Perinatal mental illness comprises the psychiatric disorders that manifest during pregnancy 
and the period up to 12 months following childbirth.10 These conditions complicate the 
antenatal and more commonly the postpartum period.10 Postpartum psychiatric disorders can 
be classified into five main categories viz.   
I) Postpartum blues 
II) Postpartum depression  
III) Postpartum psychosis 
IV) Postpartum post-traumatic stress disorder 
V) Postpartum anxiety and obsessive compulsive disorder.5  
 
2.2 Postpartum Mood Disorders  
A mood disorder is defined as a psychiatric condition characterised by an abnormality of  
emotional state.11 The postpartum mood disorders are distinguished by their onset in  
the period following childbirth and comprise a spectrum of conditions of  increasing severity 
i.e. the postpartum blues, postpartum depression and postpartum psychosis.12 
 
2.2.1 Postpartum blues  
The postpartum blues can be described as a transient disturbance in mood characterised  
by low grade depressive symptoms occurring in the first ten days following delivery. 
There are no established criteria for the diagnosis of the postpartum blues.13 It is a common 
entity occurring in 50-85% of women.12 The condition has been ascribed to rapid changes in a 
woman’s hormone levels, the stress of childbirth and the awareness of the increased 
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responsibility of motherhood.5 The symptoms are generally self limiting and do not impair 
functioning.5 They generally require only supportive interventions. Despite this, a significant 
proportion, up to 20% of patients with postpartum blues can go on to develop PPD.12,14  The 
postpartum blues are a recognised risk factor for the development of PPD.4  
 
2.2.2 Postpartum depression (PPD) 
PPD can be described as a moderate to severe emotional disturbance presenting with physical 
and psychological symptoms that define a major depressive episode as per the Diagnostic and 
Statistical Manual – edition V (DSM V). Onset of the symptom cluster occurs within the four 
weeks following delivery.10 The depressive episode of PPD has no distinctive characteristics 
that allow for discrimination from a major depressive episode occurring at any other time in a 
woman’s life.10 Studies however have shown that anxiety symptoms occur more frequently with 
PPD than with depression at other times.5 A large postpartum study that screened participants 
for PPD followed by diagnostic evaluation found that 66% of women with major depression 
had a co-morbid anxiety disorder diagnosis.15 In severe cases the depression may even reach 
psychotic proportions.13  
 
2.2.3 Postpartum psychosis 
Postpartum psychosis occurs in 0,2% of women following parturition.12 It is a psychiatric 
emergency characterised  by an acute onset of delusions and/or hallucinations frequently 
superimposed on a pre-existing affective disorder in the postpartum period. The onset is 
usually within one month of delivery. Robust data indicate that postpartum psychosis 
essentially complicates an episode of a mood disorder, usually bipolar mood disorder or 
depressive disorder.13 Women are at a greater risk of affective psychoses after birth than at 
any other time during their lives.10  Infanticide is observed in 4% and suicide in 5% of women 
with postpartum psychosis.5  
 
2.3 Postpartum Depression  
2.3.1. A global public health concern 
Major depressive disorder is the second leading cause of disability worldwide according  
to the 2013 global burden of disease study.16  The United Kingdom’s confidential enquiries 
into maternal deaths and morbidity for the period 2009-2013 reported that 23% of late 
maternal deaths which occurred after six weeks up to one year postpartum were attributed to 
mental health related issues.17  
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Women have twice the lifetime risk of developing major depressive disorder than men and the 
ages at which women have the highest rates of depression across their lifespan are within the 
reproductive years.10,18 There is substantial evidence to suggest that the risk of developing 
depression is significantly elevated following childbirth and in particular the three months 
thereafter.19 Cox et al in the first British study investigating the incidence and prevalence of 
depression in a group of postpartum women compared to non-postpartum controls found the 
period prevalence of depression to be similar in both groups.20  The results however revealed a 
threefold increase in the incidence of depression in the first month postpartum.20   This 
correlated with the earlier findings of Cooper et al who reported that 50% of newly diagnosed 
non-psychotic psychiatric illness in the postpartum period occurred within three months 
postnatally.19 In the first three months after delivery 14,5% of women have a new episode of 
major or minor depression.18,21  
 
PPD has been the focus of increasing global attention for a number of reasons. It is a common 
condition which impairs the pivotal maternal role in family and society with immediate and 
long term psychosocial morbidity. The negative effects of PPD impact on the wellbeing of the 
woman, her partner and children with recognised adverse outcomes on infant and child 
development.3 Severe PPD is associated with potentially fatal consequences to the mother and 
infant.4  
 
2.3.2 Prevalence and transcultural variation 
The prevalence of postpartum depression, as quoted in international literature, is 10-15%.5,14 
In a meta-analysis of 59 studies on PPD the average prevalence rate of non psychotic PPD 
was found to be 13%.22  Prevalence estimates in individual studies vary and are affected by the 
assessment method and the period over which prevalence is determined.10,22  
 
There is also a wide range of reported prevalence of PPD from different countries ranging  
from 0% to 60%.14 Significant transcultural variation exists in the interpretation and reporting 
of depressive symptoms.14 A systematic review by Zubaran et al. examined the cultural 
characteristics of postpartum depressive symptomology. They found that cultural forces and 
socio-economic elements influence the expression of depression resulting in regional 
variation in prevalence rates. The stigma associated with mental illness in certain cultures 
result in maternal distress manifesting as somatisation of psychological symptoms leading to 
underreporting of depressive symptoms.14  
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In 1983 Stern and Krukman postulated that PPD was an infrequent condition in non-western 
cultures. The social structure in these settings and support of mothers in the puerperium by 
women in their families and communities was thought to be protective against PPD.14 
Subsequent studies investigating the prevalence of PPD in developing countries have found 
that prevalence rates in some low resource countries are twice those of developed countries.23 
An international study by Affonso et al. sampled cohorts from nine countries, representing 
five continents, with the aim of exploring differences in postpartum depressive 
symptomology. The highest depressive symptom scores were noted in participants from Asia 
and South America and the lowest amongst European and Australian women.24 
 
 The rates of PPD vary from 4,9% to 59.4% in low resource countries.24 Although the  
physiology of pregnancy and parturition is similar in women, the event is conceptualised 
differently across cultures.18 Prevalence rates of PPD are influenced by religious practices, 
cultural norms, socioeconomic deprivation and the lack of healthcare infrastructure in 
developing countries.14 In a prospective study by Khalifa et al, 238 Sudanese women were 
screened for PPD at three months postnatally and evaluated using the Mini International 
Neuropsychiatric Interview (MINI). They established a prevalence rate of 9,2%. These lower 
than average global figures were attributed to the quality of social support in Sudan and to a 
culture that values and assigns a higher social status to women that are able to reproduce.23  
 
Comparatively, a study by Cooper et al established the point prevalence of PPD in peri-urban 
South Africa at 34.7%. This is far higher than that of Sudan as well as the widely cited 
international mean of 13%.10,25  
 
2.4 Aetiology  
Childbirth is a notable precipitant for psychiatric illness in susceptible women.26 No single 
aetiological factor is definitively implicated in the pathogenesis of PPD. A multifactorial 
aetiology is currently proposed. Biological factors appear to play a central role in the complex 
aetiology with psychosocial elements and cultural forces shaping the overall expression.14  
 
2.4.1 Genetic factors 
Major depression is a polygenetic illness and the presence of more than one vulnerable  
gene increases the likelihood of the disorder.27  The expression of certain genes may 
also influence the subtype of depression expressed.27 A single neucleotide polymorphism 
(SNP) is a genetic variation of a single base pair in the DNA sequence occurring in at least 
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one percent of the population.28 Some of the biological changes related to PPD may be 
genetically determined by polymorphisms in susceptibility genes. A systematic review by  
e-Couto et al examined the relationship between genetic factors and PPD and set out to 
elucidate the genotypes of major depression and PPD. The 20 studies included in this review, 
were conducted in ten different countries and investigated genes associated with pathways 
hypothesised in the aetiology of PPD.28 The majority of the research done focussed on 
polymorphisms of the 5HTT gene involved in serotonin metabolism, followed by genes 
associated with tryptophan metabolism, the catecolmethyl transferase (COMT) and 
monoamine oxidase (MAO) genes.28  The data supports a significant association between 
specific polymorphisms in these genes and PPD.28 As with other psychiatric disorders, genetic 
influence alone is insufficient for disease expression. Epigenetics and environmental triggers 
modify gene expression and elicit clinical disease in genetically predisposed subjects.28 The 
genetic basis for major depression and PPD are similar and the review by e-Couto et al 
concludes that PPD is a temporal variant of major depression and not a unique diagnostic 
entity.28  
 
2.4.2 Endocrine factors 
2.4.2.1 Gonadal steroids 
There are three key events that dictate the changes in gonadal steroid levels over the 
reproductive course. 
I) Pregnancy and its associated supraphysiological hormonal state 
II) The hypogonadal state of the puerperium and 
III) The resumption of cyclical ovarian function.29  
 
The hormonal milieu of pregnancy is gradually arrived at as pregnancy progresses with levels 
of oestrogen and progesterone steadily rising to reach a maximum close to term. With 
delivery and placental separation these levels dramatically decline to pregravid levels.30 The 
abrupt and rapid drop in levels of circulating oestrogen and progesterone have been postulated 
in the aetiology of PPD. Animal studies show that the precipitous withdrawal of these 
hormones alter central neurotransmission.29 Modulation of neurotransmitter systems is the 
mechanism that links the gonadal hormones to depression since an imbalance in central 
neurotransmssion is strongly hypothesised in the aetiology of depression.31  
 
Estradiol is the biologically active form of oestrogen produced by the placenta. It rises 50-100 
fold above maximal menstrual cycle levels by the third trimester of pregnancy.29,30  The 
xx 
 
biologically active free fraction of hormone also undergoes considerable increases.29 Steroid 
hormones are capable of penetrating the blood brain barrier and modulating monoaminergic 
neurotransmitter pathways.26 Estradiol increases serotonin and noradrenalin activity in the 
brain.31 It enhances serotonergic receptor density and increases the synthesis, transport and 
uptake of serotonin. Serotonin breakdown and noradrenalin metabolism is reduced by 
estradiol mediated inhibition of monoamine oxidase (MOA) enzyme activity.30,31 Following 
parturition both estradiol and progesterone levels remain low in the prolonged hypogonadal 
state that ensues. Restoration of ovulation and return of the menstrual cycle varies in lactating 
and non-lactating women with levels of estradiol and progesterone remaining at low follicular 
phase levels until approximately 30 days prior to the first menses.29  
Estradiol withdrawal has also been implicated in increasing dopamine D2 receptor 
sensitivity.26,29 Presynaptic D2 dopamine receptors function as autoreceptors. Binding to the 
D2 receptor family reduces dopamine cell firing and decreases the amount of dopamine 
released with each action potential.27,30 The decline in estradiol after delivery and the 
persistently low levels in the puerperium should therefore theoretically predispose to  
depression by reducing the intrasynaptic levels of serotonin noradrenalin and dopamine.30 
 
A study comparing estradiol levels between day one and week eight following delivery  
found no difference in levels of total estradiol in women with and those without depression.30 
Similarly a study by Mehta et al which aimed to identify early biomarkers of PPD found no 
significant differences in plasma estradiol and estriol levels in euthymic compared to 
postpartum depressed mothers.32 Levels of unbound estradiol however have not been studied 
in women with PPD and may merit examination. 30 
 
In a double-blinded randomised controlled trial, Gregoire et al examined the antidepressant 
effect of 17B estradiol supplementation in PPD. Estradiol was investigated as its mode of 
action specifically addressed the theories of PPD aetiology. The trial demonstrated the 
superiority of transdermal estradiol to placebo in relieving the dysphoric symptoms in patients 
with severe postnatal depression at baseline.33 Eighty percent of patients in the treatment  
group scored below the threshold for major depression within three months of estradiol 
therapy compared to 31% in the placebo group. Independent variables including concurrent 
antidepressant therapy were factored into the analyses and found not to significantly influence 
the outcome measured.33  
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Similarly the sharp decline in levels of progesterone following delivery has been implicated in 
postpartum mood changes.30 The proposed mechanism relates to progesterone modulating 
gamma amino butyric acid (GABA) neurotransmission. GABA is the major inhibitory 
neurotransmitter in the central nervous system. High levels of progesterone enhance GABA-A 
receptor activity inducing sedative and calming effects.34 Progesterone withdrawal reduces 
GABA activity and is linked to dysphoric mood, sleep and anxiety disorders.34 Studies have 
however failed to confirm a causal relationship between levels of total or free progesterone 
and PPD.30  
 
The response in mood to the neurobiological changes that occur with gonadal steroid 
withdrawal may be related to the rapidity of withdrawal. This is supported by the observation 
of an increased occurrence in mood disturbances following abrupt hormonal decline after 
surgical menopause compared to the gradual hormone reduction that occurs with natural 
menopause. 29 
 
2.4.2.2 Hypothalamic-pituitary-adrenal (HPA) axis  
HPA axis dysfunction is one of the most reproducible findings in major depression.29 HPA 
axis dysfunction is observed in both major depression and PPD and normalization of the HPA 
axis is associated with improved mood.29 The HPA axis in pregnancy is driven by placentally 
derived corticotrophin releasing hormone (CRH), produced by the placenta and secreted into 
maternal circulation in large amounts especially during the third trimester.29 It results in 
hypersecretion of cortisol from the adrenal glands with increased basal plasma and urinary 
cortisol levels in pregnancy.29 The feedback response to the elevated cortisol suppresses 
hypothalamic CRH levels with subsequent suppression of  pituitary adrenocorticotropic 
hormone (ACTH).29 Following parturition, plasma levels of placentally derived CRH fall 
sharply and cortisol levels decline. Suppression of the HPA axis due the down regulation of 
central CRH is however prolonged in the early puerperium. Hypothalamic CRH should 
gradually normalise within three months postpartum with a recovery in the ACTH response 
following the progressive downsizing of the hypertrophied adrenal glands.35 The suppression 
of central CRH in the early postpartum period is associated with an increased vulnerability to 
psychopathology at this time.35 Magiakou et al examined this hypothesis and found a 
pronounced and persistent blunting of ACTH response to exogenous CRH administered to 
patients with PPD compared to euthymic mothers. They suggest a potential role for ACTH as 
a biochemical marker of PPD.35  
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2.4.2.3 Oxytocin 
The role of oxytocin during labour and in the initiation and maintenance of lactation is  
well established. Recent animal and subsequent human studies support a major role of  
oxytocin in maternal behavioural adaptation. Oxytocin promotes affectionate and stimulatory 
behaviour of mothers toward their infants and improves maternal-infant attachment and 
bonding. Low oxytocinon levels during pregnancy are associated with impaired maternal 
emotional adaptation in the puerperium.36 In a prospective study Skrundz et al examined the 
association between plasma oxytocin levels during pregnancy and PPD. They concluded that 
low plasma oxytocin concentration in the third trimester is significantly associated with the 
development of postpartum depressive symptoms at two weeks post delivery.36  
 
2.4.2.4 Prolactin 
Prolactin levels rise considerably in late pregnancy and remain elevated, within physiological 
limits, for the duration of breastfeeding. In non-lactating mothers they return to pregravid 
levels within three weeks following delivery.30 Pathological hyperprolactinaemia in non-
pregnant women is associated with depression, anxiety and hostility.30 In comparison, the role 
of prolactin in postpartum psychopathology has been examined but a significant association 
between levels of prolactin and PPD has not been established.30  
 
2.4.2.5 Thyroid hormones 
Pregnancy influences thyroid function in several ways.  
I) The increased renal clearance of iodine predisposes to a relative iodine deficiency state. 
II) Placental human chorionic gonadotropin stimulates the production of triiodothyronine  
     (T3) and tetraiodothyronine (T4) by mimicking the effect of thyroid stimulating 
      hormone (TSH) on the thyroid gland.29  
III) Thyroid binding globulin levels are increased in response to elevated oestrogen.29  
The net effect of these physiological changes result in levels of T3, T4 and TSH being  
maintained within normal limits. High cortisol levels during pregnancy have an 
immunosuppressive effect followed by a rebound immune phenomenon after delivery.  
Thyroid auto-antibodies occur in 11,6 % of mothers postpartum increasing the risk of  
developing overt hypothyroidism up to four years post delivery.30  
 
The incidence of thyroid dysfunction is increased postnatally occurring at a rate of seven 
percent within the six months postpartum.30 Mood disturbances may be a manifestation of  
thyroid dysfunction as the primary pathology as hypothyroidism decreases central serotonin  
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activity.30 Abnormal thyroid hormone levels have not consistently been identified in patients 
with PPD but are of clinical relevance in a subgroup of women.29 Pop et al conducted a 
prospective study on 293 pregnant women followed to 34 weeks postpartum with the aim of 
examining the relationship between thyroid dysfunction and PPD. The incidence of thyroid 
dysfunction was found to be 7% in this cohort with depression occurring in 38% of the 
thyroid disorder group. Depressive symptoms resolved upon correction of thyroid 
abnormalities.37 Clinical suspicion should therefore prompt the evaluation of thyroid hormone 
profiles in the relevant group of patients with PPD as correcting the underlying hormonal 
irregularities confer therapeutic benefit.  
 
There is no conclusive evidence to establish a causal relationship between absolute  
hormone levels or the changes thereof and PPD. PPD is therefore not simply a condition  
of hormone deficiency or excess.29 Psychopathology in the postpartum period may be a  
reflection of extreme sensitivity to normal endocrine changes resulting in an abnormal  
response to normal hormone levels.30,32  
 
2.5 Risk Factors 
Pregnancy has historically been viewed as a period of emotional well being with parturition 
marking the culmination of months of anticipation.3,8,28 In recent years evidence to the 
contrary has been mounting. The puerperium confers an increased risk for new onset or 
recurrence of mental disorders in susceptible women.28 The experience of childbirth, the 
dramatic postpartum physiological changes and the demands of newborn care make the 
transition to motherhood a challenging time for the woman, her partner and family.5 Several 
psychological and social determinants modify the risk of developing mental illness 
postnatally. Studies examining these psychosocial elements arrive at a similar constellation of 
risk factors for PPD.4  
 
A meta analysis by O’Hara and Swain quantified the relationship between PPD and various 
risk factors examined in 77 independent studies.22 Sociodemographic and obstetric factors as 
well as the impact of adverse life events were analysed and effect sizes generated for each 
variable investigated. The following risk factors were found to be significantly associated 
with the development of PPD viz. a history of or current mental illness, marital or partner 
conflict, recent life stressors, poor social support and low socioeconomic status.3,12,22  
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2.5.1 Psychological factors 
Previous or current psychopathology has consistently been identified as the most powerful 
predictor of PPD. This includes: 
I) A personal history of a depressive disorder or other mood or psychotic disorder 
II) Previous premenstrual dysphoria 
III) Antenatal depression or anxiety  
IV) Postpartum blues in the index pregnancy.3,4,38  
Women with a significant history of serious mental illness have a 50% risk of an affective  
disorder recurring after delivery even if they are well during pregnancy.2 The results  
of the meta analyses by O’Hara and Swain indicate that a family history of depression is  
not a significant risk factor for PPD.22  
 
Pregnancy and childbirth constitute major life events. Additional stressors at a vulnerable  
time may trigger the onset of PPD.38  Life events of notable significance that impact the risk 
of developing PPD include the death of a loved one, extreme relationship changes, moving 
home and changes related to occupation or employment.38 A meta-analysis by Beck in 2001 
reviewed 84 studies on predictors of PPD and found a moderate relationship between 
perceived life stress and PPD.39  This corroborated the findings of O’Hara and Swain of a 
strong association between experiencing a life event and the development of PPD.22  
 
The transition to motherhood compels an abrupt adaptation to the various demands  
instantaneously imposed on the new mother.5 The woman has to sustain her role in  
the relationship with her partner and family members; attend to her other children and  
conform to societal and self expectations while adapting to the physiological changes of  
the puerperium and constant care of the newborn. The disruption of the circadian rhythm and  
the sleep deprivation typical of the puerperium together with any pre-existing psychosocial  
stressors may aggravate mood destabilization.5,10  
 
2.5.2 Social factors 
Social support is a multidimensional concept encompassing informational, instrumental,  
emotional support and positive reinforcement provided by one’s spouse, relatives and 
friends.38,40 In a cross sectional study examining the impact of social support on PPD amongst 
Canadian women, both teenage and adult mothers were found to be at a five times greater risk 
of developing PPD if they received minimal social support.40 Minimal support comprised 
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responses on survey of having received no, little or some support as opposed to receiving 
support most of the time or all the time.40  
 
Women diagnosed with PPD perceive their partners as being less supportive despite  
levels of actual support.38 This underrating could be attributed to the negative perceptions 
associated with depression.38 The meta analysis by O’Hara and Swain specifically examined 
support from the baby’s father antenatally as a predictor of PPD. Results revealed no 
significant association between antenatal partner support and the development of PPD but 
rather an inverse relationship between levels of support and the severity of subsequent 
depression. When analysing studies that scored the antepartum marital relationship using a 
validated scale, a small but significant association was found between low marital satisfaction 
scores and PPD.22  
 
Socioeconomic deprivation has been implicated as a risk factor for PPD.38 Despite  
methodological inconsistencies in individual studies with regard to the criteria that define  
“low” income,  meta analyses suggest women with fewer financial resources are at an  
increased risk of PPD.22,38 O’ Hara and Swain demonstrated that family income and maternal 
occupation are weak but significant predictors of PPD.22  
 
Sociodemographic variables including maternal age, level of education, parity and marital 
status were not found to be significantly associated with the development of PPD.22  
 
2.5.3 Other risk factors  
Owing to the substantial morbidity and deleterious consequences of PPD, several studies  
set out to determine additional risk factors for PPD in an attempt to timeously identify women 
at risk to enable early case detection, diagnosis and treatment. 
 
2.5.3.1 Intimate partner violence 
Woolhouse et al explored the relationship between intimate partner violence and PPD.41 From 
the Australian cohort, they concluded that emotional abuse was more common than physical 
violence or sexual abuse and that forty percent of women with PPD reported intimate partner 
violence.41 There is a strong co-morbid relationship between PPD and intimate partner 
violence and the perinatal period provides an opportunity to identify and support women 
experiencing abuse.41  
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2.5.3.2 Obstetric complications 
Results of independent studies examining the predictive value of obstetric variables on the 
development of PPD were aggregated and analysed yielding small but significant effect 
sizes.22 Perinatal complications were found to increase the risk for PPD but the mode of 
delivery was not independently associated with the development of PPD.21 Blom et al studied 
various obstetric and delivery complications as risk factors for PPD in a population of 4941 
women in Rotterdam, Netherlands. They found that twin pregnancies, the gender of the infant 
and the five minute neonatal Apgar score were not associated with the development of PPD. 
After correcting for confounders, perinatal complications found to be significantly associated 
with PPD included, pre-eclampsia, hospitalisation of the mother during pregnancy, delivery 
by emergency caesarean section, the suspicion of fetal distress and hospitilisation of the 
neonate. They concluded that the risk for PPD increased with the number of perinatal 
complications present.42 Mothers of preterm infants and infants admitted to the neonatal 
intensive care unit (ICU) are at a greater risk of PPD with aggravated symptomatology. The 
increased risk may be attributed to environmental, psychosocial and financial stressors. These 
include low lighting, the sight and sounds of medical equipment in the neonatal ICU, 
separation from the neonate, concerns regarding the wellbeing of the baby, feelings of 
helplessness and loss of the maternal role..43 
 
2.5.3.3 Body mass index (BMI) 
 In a prospective study in urban Utah, USA the association between pre-pregnancy obesity 
and PPD was explored. Participants were screened for depression at six to eight weeks 
postpartum and the impact of pre-pregnancy body mass index (BMI) on outcome was 
assessed. Obesity was found to be an independent risk factor for PPD, the relationship  
between obesity and depression being bidirectional.44  
 
2.5.3.4 Pregnancy intention 
Unintended pregnancy is common with 40% of pregnancies worldwide being unintended  
in 2012.45 Women with an unplanned pregnancy are at a greater risk of developing PPD up to 
a year following childbirth.46  
 
2.5.3.5 Risk factors for PPD in South Africa 
Meta analyses that aggregate data from a large number of studies may obscure the findings of 
smaller studies which hold significance in specific populations. The key risk factors for PPD 
as evidenced in the literature are not universally applicable to all populations groups. In the 
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meta analysis by O’Hara and Swain considerable heterogeneity in effect sizes for variables 
investigated were noted across studies, mainly attributable to the country in which the study 
was conducted and inconsistencies in the methods employed in individual studies.22  
 
Ramchandani et al examined antenatal predictors of PPD in the socioeconomically deprived, 
urban setting of Soweto-Johannesburg, South Africa.47 The only sociodemographic variable 
found to be significantly associated with PPD was maternal level of education. The higher the 
level of education attained by the mother the lower the risk of PPD.47 The strongest 
independent risk factors for PPD identified in this cohort were partner conflict and societal 
stress. Societal stress, described as witnessing a violent crime or fear that one’s life may be in 
danger is certainly unique to this study population as these mothers delivered during 1990 at a 
politically volatile and violent time in South African history.47  
 
2.6 Diagnosis 
2.6.1 Evolution of the DSM  
Perinatal mental illness has been recognised since the time of Hippocrates but has proven to 
be a concept of much debate over the centuries as childbirth related depression is not viewed 
as a distinct clinical entity.10 Research suggests that PPD is major depression recognised at a 
time of potential stress.18 The DSM is the composite of diagnostic criteria used by mental 
health professionals to determine whether a cluster of symptoms constitute a disorder.48  In 
May 2013 the American Psychiatric Association released the fifth edition of the DSM  
(DSM-V). The DSM has been reviewed from editions I to V and the diagnosis of depression 
has evolved with each revision.48  
 
PPD is not distinguished as a unique diagnostic category in the DSM but is classified as  
major depressive disorder (MDD) with “postpartum onset.” The onset specifier was only  
introduced into the classification system in 1994 with the publication of the DSM-IV.48  
Strictly defined in psychiatric nomenclature PPD is therefore MDD with postpartum onset 
occurring within four weeks following childbirth.4,12 
 
A notable revision to the diagnostic criteria for MDD in the DSM-V is the removal of the  
bereavement exclusion.48 In the previous classification, the occurrence of depressive  
symptoms within two months of a significant loss nullified the diagnosis. However in the  
current classification, the diagnosis may still be considered in the context of  a recent loss.48 
There has also been a change to the onset specifier which is now titled “with peripartum  
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onset” defined as the most recent episode occurring during pregnancy or within four  
weeks after delivery.48 Although the DSM stipulates that symptoms should occur within  
four weeks postpartum to qualify the diagnosis, many experts believe that women remain at 
risk for PPD up to a year following delivery.18  
 
2.6.2 Summary of the DSM-V criteria for MDD with peripartum onset (Appendix A) 
The presence of five or more symptoms present for most of the day almost every day for  
a two week period. Either a depressed mood or loss of interest or pleasure must be  
included to make the diagnosis.  
 
1. Depressed mood 
2. Loss of interest or pleasure 
3. Significant weight gain or weight loss 
4. Insomnia or hypersomnia 
5. Psychomotor agitation or retardation observed by others 
6. Fatigue or loss of energy 
7. Feelings of worthlessness or excessive or inappropriate guilt 
8. Diminished ability to think, concentrate or make decisions 
9. Recurrent thoughts of death or suicidal ideation, a suicide attempt or plan.49  
The symptoms must represent a change from the person’s usual state and must have a 
negative impact on the patient’s social or occupational functioning to be noted as significant. 
All these changes should not be as a result of a medical condition or substance use. 
Onset of symptoms must coincide with pregnancy or within four weeks postpartum to be 
regarded as peripartum onset.49  
 
2.7 Associated Morbidity and Complications  
Depression in the antenatal period is associated with an increased risk of adverse birth  
outcomes including preterm labour, delivery of low birth weight and small for gestational  
age infants.8,50 These complications result in the birth of premature infants who are at greater 
risk of perinatal morbidity and mortality.51 The association of antenatal depression and low 
birth weight is higher in low-income and middle-income countries.52  Field et al demonstrated 
an increased incidence of preterm labour and low birth weight outcomes in black women with 
clinical depression diagnosed antenatally in the USA.51 In their study, they found elevated 
urinary cortisol levels. The authors proposed that hypersecretion of cortisol due to underlying 
depression and stress during pregnancy offers a possible mechanism in adverse neonatal 
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outcomes.51 However, there is uncertainty as to whether the association is exclusively causal 
as maternal depression predisposes to high risk and negligent maternal behaviour including 
smoking, alcohol and substance abuse, poor nutrition and non compliance with medical 
care.10,53  
The phenomenon of fetal programming refers to the capacity of the in-utero milieu to modify 
psychobiological parameters that will persist into adulthood. Fetal programming can alter the 
risk of physical and psychological ill health and is important in determining future 
psychopathology.53 The Barker hypothesis of the fetal origin of adult disease was derived 
from the study demonstrating an association between reduced fetal growth in utero and a 
greater mortality from cardiovascular disease in adult life. Maternal nutrition was found to be 
associated with reduced fetal growth and fetal programming in this study.54 Fetal 
overexposure to cortisol and inflammatory cytokines released due to prenatal maternal stress 
may also reduce intrauterine growth and is suggested to underlie fetal programming that 
predisposes to ill health in later life.53  
 
 Behavioural problems can be observed in neonates of depressed mothers shortly after  
birth. They exhibit a discontented temperament, sleep problems and increased fearfulness.4,53  
The adverse effects of antenatal stress on the neonate can be moderated by the quality of 
postpartum maternal care.53 However, PPD impairs mothering behaviour and has a negative 
effect on maternal sensitivity.55 The nurturing and responsive tendencies of a mother to her 
newborn infant are blunted and mothers tend to be inconsistent, unavailable, withdrawn and 
hostile toward the infant.4,55  They do not engage in healthy infant developmental activities 
including reading and singing and tend to be negligent of child safety practices.55 Women 
with PPD are less likely to initiate or maintain breastfeeding.4  
 
The adverse short and long-term effects of PPD on child development are well established 
and include disturbances in various domains of development.4,52 Infants of mothers with PPD 
tend to be irritable, cry excessively, have a heightened arousal and insecure attachment. 4,52 
They display fewer facial expressions and vocalise less.18,43 The negative mother-child 
interaction predisposes to delayed neurological, cognitive, emotional and behavioural 
development.18 Persistence of maternal depressive symptoms correlates with delayed 
achievement of developmental milestones and poor cognitive outcomes.52 Emotional 
maladjustment in these children predisposes to violent behaviour, poor social competence and 
an increased risk of developing clinical depression in adolescence.52,55 Several large studies 
support the association of PPD and symptoms of attention deficit hyperactivity disorder in 
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children up to the age of sixteen52 Chronic or recurrent maternal depression is related to 
stunted growth and underweight children in low-income and middle-income countries. In 
contrast, children of mothers with chronic depression in high-income countries are at an 
increased risk of obesity, which may be related to the early cessation of breastfeeding and 
introduction of solids.52  
 
PPD has profound implications on the relationship of the woman and her partner. Marital  
discord or partner conflict constitutes both a risk factor for and a consequence of PPD.55 A 
meta analysis by Paulson and Bazemore aimed to established the prevalence of paternal 
depression from the first trimester of pregnancy up to one year postpartum. Forty-three 
studies from 16 countries were reviewed and the prevalence of paternal perinatal depression 
was established at 10.4% with the highest rates of depression experienced at three to six 
months postpartum. They analysed the correlation with maternal depressive symptoms and a 
moderate association was demonstrated.56 Although depression in one partner is moderately 
associated with the development of depression in the other, evidence is lacking to substantiate 
the role of maternal depression as a cause of subsequent paternal depression.56,57  
 
The perinatal period has been identified as a time of high risk for psychiatric hospitalisation 
especially in patients with pre-existing bipolar mood disorder and MDD.55 Untreated PPD 
poses an increased risk for postpartum psychosis, suicide and infanticide.12  The United 
Kingdom’s confidential enquiries into maternal deaths and morbidity for the period 2009-
2013 revealed that one in seven women died by suicide. Recurrent depressive illness was the 
most frequent diagnosis accounting for almost half of all deaths by suicide.17 The maternal 
psychiatric diagnosis was a depressive disorder in all cases of extended suicide where the 
baby or older children died with the mother. Maternal suicide is more likely to be violent with 
82% of suicides in this enquiry completed by violent means demonstrating clear intent.4,17  
 
Neonaticide is defined as the killing of a newborn within 24 hours after birth and is described 
when the pregnancy is unwanted in two subsets of patients. The first being a woman that is 
deliberately concealing her pregnancy while the other is a victim of a dissociative disorder 
with amnesia or depersonalisation surrounding the delivery.4,58 Infanticide is the killing of an 
infant in the first year of  life and may occur in the context of severe PPD as a result of abuse 
or neglect by the mother. This may happen as the child is unwanted or as revenge against the 
infant’s father.4 Depression complicated by psychosis has a greater association with 
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infanticide as opposed to non-psychotic maternal depression. In comparison to depression that 
may occur at other times in a woman’s life, guilt occurs more frequently in PPD.4,30 
Obsessional thoughts relating to accidental or intentional harm to the infant are frequently 
experienced by mothers with PPD but rarely acted upon unless the condition reaches 
psychotic proportions.58 In extreme cases intrusive thoughts coupled with the guilt that one is 
a bad mother may drive a woman to commit dual infanticide-suicide for perceived altruistic 
reasons. Between16-29% of mothers who kill their children commit suicide.4 The paradox of 
infanticide is that the perpetrator may themselves be a victim of a psychiatric disorder. It is 
this recognition that underlies the legal disparity in different judicial systems. The Infanticide 
Act enforced in England mandates probation and psychiatric treatment for mothers guilty of 
infanticide.58 This is in contrast with the United State’s legislation that imposes a lengthy 
sentence or even the death penalty for the convicted mother. Interestingly, there is no 
difference in the prevalence of infanticide between these two countries.58  
 
Inadequate treatment of PPD increases the risk of chronic depression, recurrent or refractory 
disease.12 More than half of all women with PPD remain symptomatic a year later.59 A 
substantial proportion of mothers with apparent refractory depression suffer from 
undiagnosed bipolar mood disorder and antidepressant monotherapy in these patients 
precipitates rapid cycling, mania and treatment resistance.10 
 
2.8 Screening 
2.8.1 Rationale for screening 
Many studies have documented that PPD is both highly prevalent and debilitating and 
although effective treatment is available fewer than half of all cases are recognised.18 Guilt is 
frequently associated with PPD preventing mothers from divulging their mood and anxiety 
symptoms.4,30 There is often misinterpretation and minimisation of symptoms by the patient, 
family and even health care providers.29 Changes in sleep patterns, appetite and energy levels 
may be considered characteristic of the puerperium further obscuring the diagnosis.14  
 
Screening for depression in the postpartum period can improve the rate of detection and 
treatment of PPD.14,18 The findings from a survey of members of the Washington Academy of 
Family Physicians revealed that the majority of physicians routinely screened for PPD but did 
so informally with only thirty percent of physicians using a validated instrument.59 Informal 
assessments of PPD have proven to be ineffective in case detection.18 A number of studies 
examining routine postpartum screening in various cohorts using a validated instrument were 
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consistent in their findings that screening improved the rate of diagnosis and subsequent 
treatment of PPD.18 A systematic review of fourteen randomised control trials on screening 
for general depression in primary care found that screening with feedback to the primary 
health care provider increased the detection of depression two to three fold but did not always 
improve clinical outcomes.18,60 Screening in collaboration with referral pathways directed 
toward treatment and follow up was associated with more positive patient outcomes.60  
Screening is feasible on an outpatient basis and the majority of mothers are comfortable with 
the idea of being screened for PPD.18 Convenient opportunities for screening are provided by 
the mother’s postpartum visit and the infant’s well child visits. The well child visit provides a 
longitudinal opportunity to screen throughout the first postpartum year.18 Primary health care 
personnel, obstetricians and paediatricians should be responsible for screening at these 
times.14  Barriers to screening include the lack of expertise, time constraints and the concern 
of legal vulnerability on the part of the clinician particularly if the mother is suicidal. Poorly 
integrated primary health care and mental health services without strategies for referral 
compound the reluctance of physicians to screen for PPD.4,18 Patient related barriers to 
screening and referral include social stigma, multiple health care worker visits and increased 
transport and health care costs. In addition obstacles unique to the puerperal mother include 
childminding during consultations; the effects of medication on the infant while breastfeeding 
and the fear of referral to child protection services.18  
 
 A structured clinical interview should always follow screening to confirm the diagnosis.18 
Prompt diagnosis allows for early intervention promoting a healthy mother-infant relationship 
and improved developmental outcomes for the child.14 Screening for PPD is currently 
recommended in Australia and the USA and the policy in the UK is toward opportunistic case 
finding.61 South Africa at present does not have a screening policy in place for PPD.  
 
2.8.2 Screening instruments 
The National Institute for Health and Clinical excellence’s (NICE) guideline for antenatal  
and postnatal mental health recommends the use of the two question screen at every visit 
throughout pregnancy and the puerperium.61  
1. During the past month have you been bothered by feeling down, depressed or  
       hopeless? 
2. During the past month have you been bothered by having little interest or  
             pleasure in doing things? 
A positive response to either or both questions should prompt further assessment using  
xxxiii 
 
the EPDS or the Patient Health Questionnaire (PHQ-9).18,61,62 
 
A systematic review of thirty-six studies on screening for PPD evaluated eight screening  
instruments. The results of this review suggested that the EPDS is the most extensively 
studied screening scale with moderate psychometric soundness.18 The Patient Health 
Questionnaire (PHQ-9) is a nine item self report instrument that evaluates depressive 
symptoms as per the diagnostic criteria for major depression. It measures the severity of 
depression by rating the frequency of symptoms experienced. The psychometric properties of 
the questionnaire confer validity for use in screening and monitoring of general depression but 
the instrument has not been validated for PPD.18 
 
Other tools that have been developed include the postpartum depression screening scale 
(PDSS) and the Bromley postnatal depression scale (BPDS). The PDSS has been developed 
more recently as a self report instrument to identify PPD.14 It evaluates seven conceptual 
domains of maternal mental well being viz. sleep and appetite disturbances, anxiety or 
insecurity, emotional lability, cognitive impairment, loss of self esteem, guilt or shame and 
suicidal thoughts. These seven themes emerged from the author’s previous qualitative 
research on the maternal experience of PPD. Each of the seven domains are assessed by five 
introspective statements resulting in a 35 item instrument. The responses to each item are 
indicated in grades of agreement or disagreement with the statement using a likert scale. Items 
are scored based on severity with the total possible score ranging between 35-175. Using a 
threshold score of 80 to indicate major depression, the first validation study performed using 
this instrument demonstrated a sensitivity of 94% and a specificity of 98%.14 
 
The BPDS developed in 1992 is a ten item instrument which identifies previous and pre-
existing episodes of PPD.14 It allows the reporting of mood and behaviour symptoms 
pertaining to the current and past pregnancies and postnatal periods thereby establishing a 
temporal course of depressive symptomology. Evidence to substantiate its reliability is 
however limited.14  
 
2.8.3 The Edinburgh Postnatal Depression Scale (Appendix B) 
The EPDS was developed by Cox et al in 1987 in response to the findings of their earlier 
studies. A prospective study they conducted in 1982 recruited 101 participants antenatally and 
followed them up postnatally. Thirteen out of the 101 participants were found to have marked 
postnatal depressive illness. The majority of these mothers received no treatment and were not 
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referred to psychiatric services by their primary health care provider. The three women who 
were actually referred to psychiatric services were found not to be depressed.63 A follow up 
study found that half of the mothers diagnosed with depression had not recovered by one year 
postpartum.64 This was a cause for much clinical concern. The emphasis of screening scales 
for general depression is mainly on somatic symptoms which may be attributed to the 
physiological changes of the puerperium. Having identified the limitations of conducting 
screening scales for general depression on postnatal mothers a need to develop a screening 
instrument specific for PPD was realised and addressed.64 Existing instruments were analysed 
by Cox et al and items suitable for detecting PPD were extracted and adapted appropriately. 
The initial scale comprised thirteen items; six adapted from the Irritability, Depression and 
Anxiety scale (IDA) and the Hospital Anxiety and Depression Scale (HAD) and seven newly 
constructed items. Two items relating to irritability and one item concerning the ‘enjoyment 
of motherhood’ were considered to be non-depression factors and subsequently removed to 
improve the specificity of the final instrument.64  
 
The EPDS is a ten item self report scale evaluating symptoms experienced in the past  
seven days. It measures the emotional symptoms of PPD with less emphasis on somatic  
symptoms except for one item measuring sleep difficulties.14 Each item has a scaled response 
based on the severity of the symptom experienced and is scored between 0-3 in increasing 
severity. The total possible score is between 0-30. A score of ten or greater indicates possible 
depression and is a marker for minor depression while a score of 13 or greater identifies 
probable depression or major depression.61 The scale was validated on 84 potentially 
depressed participants at six weeks postnatally and found to have a sensitivity of 86%, a 
specificity of 78% and a positive predictive value (PPV) of 73% at a threshold score of 13.64  
 
The EPDS has since then been tested at different cut off points in various subgroups in a 
number of countries and languages yielding variable psychometrics.14 A systematic review of  
thirty-seven studies validating the EPDS investigated whether the instrument compared  
favourably to a structured clinical interview in detecting PPD across various settings.  A large 
variation in estimates of sensitivity and specificity between studies was found. The degree of 
heterogeneity suggested that the EPDS is not an equally valid screening tool across all 
cultures.61 The accuracy of the tool depends on the clinical setting and the country and 
language of administration. A cut off point of 12 or 13 was found to provide strong evidence 
for the presence of major depression but did not convincingly exclude the disorder.61 
Therefore in selecting a threshold score for a particular study population the importance of 
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ruling in compared to ruling out the disorder has to be considered based on the characteristics 
of the population, the availability of resources and the impact of over-diagnosis versus missed 
diagnosis.61 The sensitivity of the scale is influenced considerably when translated into other 
languages and the tool may be most sensitive when administered in English.61 A study by 
Matthey et al examined the use of unvalidated cut off scores and the impact of different 
wording or formatting of the EPDS. They recommended that a threshold score of 13 or more 
be used when reporting on probable major depression in postnatal English speaking women 
and that the scale should be worded and formatted as originally described by the authors.65  
 
2.9 A South African Perspective  
Perinatal depression has received increasing interest in South African literature especially 
over the past two decades. A study conducted by Cooper et al on the impact of PPD on the  
mother-infant relationship in the peri-urban settlement of Khayelitsha, Cape Town in 1999 
established the point prevalence of PPD at 34.7%.25 In a later study on the prevalence of PPD 
in HIV infected mothers in the Nkangala district of Mpumalanga, Peltzer and Shikwane 
reported a 45,1% prevalence of PPD in this subgroup.66 These figures indicate a high 
prevalence of PPD in peri-urban or rural South Africa. Whether these prevalence rates can be 
extrapolated to the population at large is uncertain. The EPDS was used as a screening 
instrument in the latter study as well as in a study by Mannikam and Burns to determine the 
prevalence of antenatal depression at a teaching hospital in Kwazulu Natal.8 The EPDS had 
been validated for use in South Africa by Lawrie et al at Coronation Hospital, Johannesburg 
in 1998 (The hospital has since been renamed RMMCH). They reported a sensitivity of 
76.0% and a specificity of 81.8 %; a PPV of 51.3% and a negative predictive value (NPV) of 
91.3% at a threshold  score of 12 or 13 for major and minor depression combined.67 Following 
the validation of the EPDS in this trial, the authors used it in a subsequent randomised 
controlled trial to investigate the effect of norethisterone enanthate administration on the later 
development of PPD.68 They found that the use of injectable progestogen within forty-eight 
hours following delivery was associated with an increased risk of developing PPD.68  The  
proposed mechanism underlying this association being that synthetic progestogens suppress 
endogenous progesterone which has mood elevating properties.68 
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3. Problem Statement and Aim 
Maternal mortality remains the most discrepant health indicator between the developed  
and developing world. A mother has a one in sixteen chance of dying from pregnancy and  
childbirth related complications in sub-Saharan Africa compared to a one in four thousand 
risk in the developed world.6 The millennium development goals endorsed in 2001 aimed for 
a three quarter reduction in maternal mortality ratio by the year 2015. This commitment to 
maternal health has been reaffirmed by the sustainable development goals which aims for a 
reduction in the global maternal mortality ratio below seventy per hundred thousand live 
births by 2030.7 South Africa is striving toward reducing maternal and perinatal mortality 
with policies and priority directed at this aim. Both antenatal and postnatal care delivered to 
patients accessing public health services focuses predominantly on physical health.8  The 2015 
Guidelines for maternal care in South Africa lists counselling and advise for ‘mood problems’ 
amongst other concerns to be addressed at the three to six day postnatal visit without further 
mention or elaboration.9 Maternal mental health, despite its prevalence and associated 
morbidity remains a neglected part of obstetric care and no routine screening policy for PPD 
is currently recommended in South Africa. 
 
Studies on the prevalence of PPD in the general urban postnatal population of South Africa 
are lacking. The aim of this study was to determine the proportion of mothers at risk of 
developing PPD, by screening women who delivered at Rahima Moosa Mother and Child 
Hospital (RMMCH) for PPD at six weeks postnatally using the Edinburgh postnatal 
depression scale (EPDS). 
 
4. Objectives 
I. To determine the proportion of women who delivered at RMMCH who are at risk of PPD 
using the EPDS at six weeks postnatally 
II. To analyse sociodemographic, medical and obstetric data with respect to outcomes. 
III. To compare screen positive to screen negative patients and comment on correlations   
     between possible predisposing factors and outcomes. 
 
5. Methodology 
5.1 Study Design 
The study is a prospective observational cohort study conducted on 200 participants with  
the exposure being parturition and the outcome PPD.  
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5.2 Study Approval 
The research protocol was submitted and approved by the University of Witwatersrand’s  
Human Research Ethics committee (number: M141015) and institutional approval was 
obtained from the CEO of RMMCH. (Appendix D) 
 
5.3 Study Setting  
RMMCH is a regional hospital affiliated to the University of Witwatersrand. It serves  
region B and part of region C of the Johannesburg metropolitan area, receiving high risk  
referrals from local clinics. Region B comprises a number of residential areas including 
Rosebank, Bryanston and Randburg and region C areas including Thulani, Florida and 
Bramfischerville. Patients accessing care arise mainly from low income households and a 
growing immigrant population in the catchment area. There is only one midwife obstetric unit 
(MOU) that delivers intrapartum care to this community. The Discoverers MOU conducts 
approximately one hundred deliveries monthly. Therefore, in addition to referrals, many low 
risk pregnancies are delivered at RMMCH. There are on average 800 to 1000 deliveries per 
month at the hospital with one third of the patients comprising foreign nationals. The patient 
population at RMMCH is therefore representative of the general obstetric population in the 
area served.  
 
5.4 Study Population  
English speaking women who delivered a live baby after 26 weeks completed weeks of  
gestation, either by vaginal delivery or caesarean section at RMMCH were recruited  
immediately postpartum during the period April to July 2015. Minors, under the age of  
eighteen were not included in the study. Demise of the infant prior to the six week  
follow-up was a criterion for exclusion.   
Intrauterine fetal demise or the loss of or an infant following delivery is associated with   
distinct grief and requires prompt psychiatric assessment and management as part of  
standard care. Early intervention in the form of support and counselling can prevent the  
progression of grief into a pathological condition.69 Patients that suffered such losses were not 
included in the study sample to be screened for PPD later as the immediate referral to 
psychiatric services was warranted in these patients.  
 
Non-English speaking patients were excluded from the study to allow the psychometrics  
of the EPDS to confer maximum validity. The participants’ proficiency in English were  
not objectively determined. The patient’s preferred language of communication was  
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established at recruitment and they were asked if they understood and were comfortable  
with being spoken to in English. They were then asked if they could read English and 
sufficiently understand the written language. A subjective competence affirmed by the 
participant was taken as an indication of proficiency in English.  
 
The World Health Organisation (WHO) defines the years between ages 15 to 44 as the female 
reproductive years. An adolescent female is 15 to 19 years old and an adult female is 20 years 
or older (according to South African law, an adult is 18 years or older).70 The Royal College 
of Obstetricians and Gynaecologists (RCOG) identifies the optimal biological period for 
childbearing as the years between ages 20 to 35, recognising that fertility and pregnancy 
outcomes change with age.71 Advanced maternal age is defined as pregnancy in a woman 35 
years or older.72 The age of participants were recorded and analysed based on these 
obstetrically relevant age categories. 
 
Poverty lines in South Africa define the levels below which earnings constitute poverty. In  
2014 the income level below which one is able to afford food and non-food necessities  
but is still considered impoverished was set at R753 per person per month.73 Monthly 
household income was stratified with the lowest level corresponding to the poverty  
threshold (Appendix C). 
 
Postnatal mothers were recruited by random sampling using an electronic random number 
generator from the delivery records in labour ward and caesarean section theatre in a two-
third to one-third proportion i.e. for every two patients randomly selected from the register in 
labour ward, one patient was selected from theatre records. The objective was to generate a 
study sample that would reflect the caesarean section rate at RMMCH of 33.2% (from 01 July 
2013 to 30 June 2014) and therefore be 
representative of the general obstetric population. Inclusion and exclusion criteria were then 
applied to potential participants and patients that qualified were invited to participate in the 
study.  
 
5.5 Data Collection  
Written informed consent was obtained from participants while hospitalised immediately  
post-delivery. A sociodemographic, obstetric and medical questionnaire (Appendix C) 
was then completed by interview and review of the patients’ hospital records. At the end of 
the enrolment interview participants were given an example of a Likert scaled question in 
xxxix 
 
order to familiarise them with the construct of questions they will be asked at the screening 
interview.  
 
Participants were contacted telephonically at a pre-arranged time at their convenience six 
weeks post-delivery to complete the follow up interview and EPDS. The identities of mothers 
were verified at the onset of the interview by asking them to confirm both their own and their 
infant’s dates of birth. An enquiry regarding the wellbeing of the baby was made. If this 
revealed that the infant had demised, the mother was excluded from the study but referred to 
the department of psychiatry for further management.  
 
Participants who were eligible for screening were reminded about the study and that the  
purpose of the telephonic interview was to complete the screening instrument. Their 
willingness to participate further was confirmed. A text message containing the EPDS was 
then sent to the patient on their cellular phone to allow them to read the questions at their 
leisure and a follow up appointment scheduled to complete the interview. Participants were 
again contacted telephonically as scheduled and their understanding of the questions on the 
EPDS established. The researcher then completed each item of EPDS with the participant. In 
addition, all mothers were asked if they had considered harming their babies. The score was 
then tallied and they were informed of their performance and the interpretation of the score.  
 
Mothers that screened positive with a total score of thirteen or greater or responded positively 
to having thoughts of self or infant harm were offered referral to the department of psychiatry 
at RMMCH. All patients that declined further psychological assessment offered an 
explanation for their decision. At the end of the interview all participants were encouraged to 
contact the researcher should they develop any symptoms of depression at a later stage and a 
five rand airtime voucher was then transferred to their cellular phones to facilitate this.    
 
5.6 Data Analysis 
Data was captured electronically onto the REDCap data collection programme and analysed 
using Stata Version 11 (Statacorp, College Station, Texas, USA). Categorical variables were 
analysed and reported as frequencies and percentages. Continuous data were reported using 
means and standard deviations. Possible explanatory variables to outcomes measured were 
dichotomized. Binary variables were then tabulated against screen outcomes and  
non-parametric tests viz. Pearson’s Chi-squared and Fischer’s exact tests were conducted. A  
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p-value ≤ 0.05 conferred statistical significance. Variables that were not significantly 
associated with the outcome measured but were found to exhibit a trend were analysed further 
using multiple backward logistic regression. 
 
5.7 Funding 
A five rand airtime voucher was issued to participants after the telephonic interview 
to allow them to contact the researcher should symptoms develop at a later stage. 
The airtime vouchers were sponsored by Dr Karlyn Fran 
 
6. Results 
6.1 Sample 
Of the 217 patients that were randomly selected for participation, seventeen were excluded 
prior to recruitment as nine were non English speaking, three were minors and five had 
delivered a stillbirth.  A further four patients were excluded at follow up due to infant demise 
and eighteen participants were lost to follow up resulting in 178 patients finally being 
screened for PPD. (Figure 6.1) 
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Figure 6.1 Selection of final sample 
6.2 Sociodemographic Characteristics 
 
6.2.1 Age  
Participants were aged 18 to 43 years with a mean age of 27.5 (standard deviation (SD) ±  
5.94) years. The majority (81.0%) of participants were in the optimal childbearing age group. 
Adolescent mothers comprised 5.5% of the sample and mothers of advanced age the 
remaining 13.5%. (Figure 6.2) 
 
 
 
 
 
 
 
 
 
Figure 6.2. Scatterplot of participants’ ages.                                            
                                                                                    
                                                                                                                
6.2.2 Race 
The racial distribution of the cohort comprised 75.0% black patients, 17.5%  
colour4.0% Asian and 3.5% white patients. (Figure 6.3) 
 
 
Figure 6.3: Racial distribution of participants 
 
Racial Distribution %
Black- 75
Coloured- 17.5
Asian- 4
White 3.5
Lowest value: 18 
Highest value: 43 
Mean: 27.5 
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6.2.3 Nationality 
Sixty-seven percent of the study population were South African nationals and 33.0% were  
immigrants mainly from Zimbabwe, Malawi and Somalia. (Figure 6.4) 
 
Figure 6.4: Nationality  
 
6.2.4 Level of education  
Overall it was a well-educated cohort with 98.0% of participants having received 
secondary education and 69.0% attaining a grade twelve or higher qualification.  
 
6.2.5 Employment status   
Unemployed mothers comprised 59.5% of the sample and 40.5% of participants were 
employed.  
 
6.2.6 Relationship status   
A third (33.5%) of participants were married, 59.5% were co-habitating or in a relationship 
with their partners at recruitment and 7.0% were single mothers. 
 
6.2.7 Monthly household income (Table 6.1). 
One third (34.0%) of participants earn an income below the poverty threshold.73 
 
 
Table 6.1 Monthly household income of study sample 
Nationality %
South African- 67
Zimbabwean- 23
Malawian- 6
Somalian- 1.5
Other- 2.5
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6.2.8 Residence post delivery  
Most mothers (89.0%) returned to a house or flat after delivery with the remaining 11.0%  
residing in informal settlements. Almost all (98.5%) have access to electricity and running  
water. Those homes without electricity rely on paraffin as a source of energy.  
 
6.2.9 Support structures 
Three percent of women reported having no support system in the puerperium. Amongst the 
participants that have support, 28.8% relied on their partners as the main support person and 
the remainder on family and friends.  
 
6.3 Medical and Obstetric characteristics  
 
6.3.1 Parity (Table 6.2) 
Primiparous mothers comprised 32.5% and grand multiparous females 2.5% of the postnatal 
sample with the majority of mothers (61.0%) having delivered their second or third babies 
 
Table 6.2 Parity of women recruited to the study 
 
 
 
 
 
 
 
6.3.2 
Pregn
Monthly household income Frequency (N=200)   Proportion %  
<  R2000 68 34.0  
R2000 -  R5000 77 38.5  
R5000 - R10 000 36 18.0  
> R10 000 19 9.5  
Parity Frequency (N=200) Percentage (%) 
1 65 32.5 
2 70 35.0 
3 52 26.0 
4 8 4.0 
5 4 2.0 
8 1 0.5 
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ancy Intention  
The proportions of planned and unplanned pregnancies were almost equal in the study 
population with 47.5% of pregnancies planned and 52.5% unplanned. With the exception of 
one patient 99.5% of mothers wanted to keep their babies following delivery regardless of 
previous pregnancy intention. 
 
 
 
6.3.3 Pregnancy type 
The majority (97.5%) of pregnancies were singleton, the remainder (2.5%) were twin 
pregnancies. 
 
6.3.4 Gestational age (Table 6.3) 
The mean gestational age at delivery was 38.0 (SD ± 2.30) weeks with a range of 29 to 42  
weeks. Forty-three deliveries were preterm below a gestational age of 37 completed weeks. 
This constituted 21.5% of the total deliveries. The gestational age in 125 (62.5% ) patients 
was calculated using the last normal menstrual period. Other methods of dating used included 
early ultrasound in 43 (21.5%) patients,  first palpation of the symphyseal-fundal height in 19 
(9.5%) and late ultrasound in 13 (6.5%) patients. 
 
Table 6.3 Gestational age at delivery 
   Gestational age (weeks) Frequency (N=195) 
      [Twins (N=5)] 
Percentage (%) 
29 2 1.0 
30 1 0.5 
31 2 1.0 
32 1 0.5 
33 2 1.0 
34 5 2.5 
35 7 3.5 
36 23 11.5 
37 27 13.5 
38 35 17.5 
39 45 22.5 
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40 27 13.5 
41 19 9.5 
42 4 2.0 
 
 
 
 
 
 
6.3.5 Human Immunodeficiency Virus (HIV) infection 
The majority (85.5%) of patients tested negative for HIV antenatally with 14.5% of the  
study population being HIV infected. Of the HIV infected patients 93.1% were on 
antiretroviral therapy at recruitment. The CD4 count was unknown in 55.2% of HIV infected 
individuals and the CD4 count ranged from 62 – 1026 cells/mm3 in the remaining 44.8%. 
Nine patients had a CD4 count below 500 cells/mm3. 
 
6.3.6 Co-morbidities 
The frequencies of associated medical, obstetric and psychiatric conditions are tabulated 
(Table 6.4). Two patients had more than one condition. 
 
Condition Frequency (N = 202) Percentage (%) 
Chronic Hypertension 5 2.5 
Gestational Hypertension 12 6.0 
Pre-eclampsia 5 2.5 
Pregestational Diabetes mellitus 2 1.0 
Gestational Diabetes mellitus 4 2.0 
Epilepsy 2 1.0 
Asthma 3 1.5 
Cardiac conditions 0 0 
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 Table 6.4 Co-morbid conditions of study sample 
 
 
 
 
6.3.7 Psychiatric history 
One patient had a history of PPD in a previous pregnancy and three patients reported a history 
of depression in a first degree relative. One participant was suicidal having attempted an 
overdose on antenatal supplements during the index pregnancy. This patient was admitted and 
referred to both psychiatric and social services. 
 
6.4 Perinatal Events 
 
6.4.1 Mode of delivery  
Approximately two thirds (65.5%) of the study sample delivered vaginally and 34.5% by 
caesarean section. Included in the vaginal deliveries were patients who required assisted 
deliveries as well as successful vaginal births after caesarean section which each comprised 
1.5% of the total deliveries (Figure 6.5). 
 
Anaemia in pregnancy 6 3.0 
Current psychiatric disorder 1 0.5 
No co-morbid condition 162 81 
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Figure 6.5: Mode of delivery 
 
 
 
 
 
 
 
6.4.2 Characteristics of parturition 
6.4.2.1 Induction of labour 
Labour was induced in 6.0% of participants for indications as tabulated (Table 6.5). Of these 
mothers, 58.3% delivered vaginally and 41.7% by caesarean section. The indications for 
caesarean section were suspected fetal compromise in 60.0% of patients and poor progress in 
the remaining 40%.  
 
Table 6.5 Induction of labour- Indications and delivery outcomes in participants recruited 
62.5
25.5
9
1.5 1.5
Mode of Delivery %
NVD
Emergency c/s
Elective c/s
Assisted
VBAC
Vaginal Delivery - 65.5%
C-Section - 34.5%
 
Indication 
Frequency 
 
(N=12) 
Percentage (%) 
of inductions 
Vaginal 
Delivery 
(N=7) 
Caesarean 
Section 
(N=5) 
Prelabour rupture of membranes at term  4 33.3 2 2 
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6.4.2.2 The duration of labour 
The mean duration of the latent phase of labour from first assessment was 7.8 (SD ± 5.2)  
hours with a range of one to twenty-four hours. The active phase of labour ranged from  
0.5 to 17.0 hours with a mean of 4.4 (SD ± 3.8) hours. Prolonged labour defined as a  
greater than six-hour duration in active phase occurred in 19.9% of participants. The  
duration of the second stage of labour ranged from one to ninety minutes with a mean of  
16.6 (SD ± 14.7) minutes.  
 
6.4.2.3 Support and analgesia in labour 
The majority (71.8%) of patients were not accompanied by a support person in labour and a 
large proportion (67.9%) received no analgesia in labour. The partogram and prescription 
charts were reviewed to obtain information regarding analgesia administered in labour. 
Patients that received analgesia were given either intramuscular opioids and anxiolytics or had 
epidural analgesia.  
 
 
6.4.3 Caesarean section  
Emergency caesarean section accounted for 73.9% of total caesarean deliveries, the  
remaining 26.1% were elective cases. Indications for caesarean section are tabulated   
(Table 6.6). 
 
Table 6.6 Indications for caesarean section in participants recruited to the study 
Postdates 2 16.7 2  
Hypertensive disease at term 3 25 2 1 
Diabetes mellitus at term 1 8.3  1 
Intrauterine fetal growth restriction  1 8.3 1  
Poor obstetric history  1 8.3  1 
Indication     Frequency 
      (N =69) 
Percentage (%) of total 
caesarean sections 
Suspected fetal compromise 25 36.2 
Previous caesarean section            24             34.8 
Poor progress 7 10.1 
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6.4.4 Complications  
Following vaginal delivery, retained products requiring evacuation of the uterus occurred in 3 
patients (2.3%). Twenty-seven (20.6%) patients that delivered vaginally required an 
episiotomy to facilitate delivery and 8 (6.1%) sustained second degree tears. No patients 
sustained third or fourth degree tears and one case necessitated examination under anaesthesia 
to repair extensive tears. One patient had a postpartum haemorrhage secondary to uterine 
atony following vaginal delivery and was successfully managed medically. Haemorrhage at 
caesarean section resulted in a hysterectomy in one patient. No other major intra-operative 
complications occurred.  
 
 
 
 
 
 
 
6.5 Neonatal Outcomes 
6.5.1 Birth weight  
The mean infant birth weight was 2976.2 (SD ± 586.1) grams (g) with a range of 810.0 to  
4610.0g. Low birth weight infants (less than 2500g) comprised 38 neonates (18.5%) of the 
total sample), 30 (78.9%) of low birth weight infants were born at term. 
 
6.5.2 Gender  
The neonatal population comprised 51.2% males and 48.8% females. Overall 97.5% of  
mothers were happy with the gender of their babies. The remaining 5 mothers (2.5%) had  
hoped for a baby of the opposite gender. 
 
6.5.3 The five minute Apgar score  
Cephalopelvic disproportion  3 4.4 
Malpresentation  3 4.4 
Prolonged second stage of labour 2 2.9 
Twins 2 2.9 
Antepartum haemorrhage 1 1.4 
Other 2 2.9 
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The neonatal Apgar score at five minutes after birth ranged between 2 and 10. The median 
and mode were both 10. 
 
6.5.4 Neonatal admission 
Twenty-eight (14%) of neonates required admission following paediatric assessment after 
delivery. The duration of separation from their mothers ranged from one to seventy-two 
hours. For babies that were admitted to the paediatric ward at the time of recruitment, the 
duration of separation was calculated up to the time of the enrolment interview. 
 
6.5.5 Method of feeding  
The majority (93.0%) of mothers opted to breastfeed. Amongst the 6.0% who chose to  
formula feed, the majority (71.4%) were HIV infected. Reasons stated other than the  
desire to decrease HIV transmission to the neonate, were mothers having to return to  
work and difficulty breastfeeding previously.  
 
 
 
 
 
 
 
 
 
6.6 Follow-up interview and screening  
6.6.1 Population screened 
The mean follow up at which the EPDS was completed was 8.0 (SD ± 2.6) weeks. Nine  
percent of the participants recruited to the study were lost to follow up as they were not  
reachable at the contact numbers provided at enrolment. A further 2.2% were excluded  
at the time of follow up due to infant demise after the enrolment interview. This resulted in a 
final sample of 178 participants being screened for PPD.  
 
6.6.2 Results of screening  
The main outcome measured was a screen positive score (≥ 13) on the EPDS or a positive 
response to the items relating to self or infant harm. Twenty-seven percent of the final sample 
screened positive for being at risk of PPD. The mean score on the EPDS was 9.1 (SD ± 5.5, 
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range 0 - 23). Two participants scored below the threshold of 13 but were screen positive 
based on thoughts of deliberate self-harm. Both these patients had a score of 11. Of the screen 
positive participants, 39.6% responded positively to the question on self-harm and one patient 
(2.1%) had considered harming herself as well as her baby. (Figure 6.7) 
 
6.6.3 Referral  
All screen positive participants were referred to the department of psychiatry at RMMCH 
for formal evaluation and treatment. Over half (54.2%) declined referral for various reasons 
including time constraints; having adequate social support and opting for treatment in the 
private healthcare sector. All these patients were offered an unrestricted opportunity to access 
psychiatric care at the hospital at their convenience should they choose to do so. These 
patients were followed up after the screening interview to ensure their wellbeing and remind 
them of the services available to them at RMMCH. Text messages with the details of the 
department of psychiatry were sent to their mobile phones and all participants were 
encouraged to contact the researcher for any assistance in this regard. (Figure 6.7) 
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Figure 6.6 Screening and referral outcome of women delivered at RMMCH and screened for 
PPD by EPNDS at six weeks postnatally 
 
 
 
 
 
 
 
 
 
6.6.4 Characteristics of the screen positive population  
The mean age of participants found to be at risk of PPD was 26.6 (SD ± 5.2) years, with a 
range 18 to 42 years. The racial distribution of the screen positive subgroup comprised 70.8% 
black, 22.9% coloured, 4.2% Asian and 2.1% white patients. Participants who screened 
positive were mainly South African (64.5%). Approximately two thirds (68.8%) of the screen 
positive cohort completed grade twelve but the majority (58.3%) were unemployed with 
35.4% arising from households with a monthly income below R2000.  
 
Almost one third (31.3%) of the screen positive population were first time mothers. Of the 
screen positive group, 8.3% were HIV infected and 12.5% had a co-morbid medical or 
obstetric condition. Three quarters (75%) of mothers with probable major depression 
delivered vaginally and 25% by caesarean section. Amongst participants that delivered 
N= 28 (58.3%) 
No thoughts of self 
or infant harm  
selected 
N= 26 (54.2%) 
Declined referral 
N= 48 
Referred to 
psychiatry 
 
N= 22 (45.8%) 
Accepted referral 
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vaginally and screened positive for PPD, 23.3% had prolonged labours in the active phase, 
64.3% had no support and 59.5% received no analgesia in labour. Male infants were born to 
52.1% and female infants to 47.9% of screen positive mothers. Amongst mothers whose 
infants were admitted to the paediatric ward post-delivery, 16.7% screened positive for PPD. 
(Table 6.7) 
 
6.7 Associated variables 
Categorical variables representing potential risk factors for PPD were cross-tabulated  
against screen outcomes. Sociodemographic variables tested included adolescent mothers, 
mothers of advanced maternal age, race, nationality, level of education, employment status, 
low income and marital status as well as residence and support post-delivery. Obstetric 
variables tested against outcomes comprised first-time mothers, pregnancy intention, single 
and multiple gestations, preterm delivery, induction of labour, mode of delivery, prolonged 
labour, second degree tears and episiotomies, support and analgesia during labour. Too few 
complications occurred following vaginal delivery or intra-operatively at caesarean section to 
examine the impact of complications on screen positive outcomes. Medical variables tested 
included the presence of co-morbid conditions and HIV status. Variables relating to neonatal 
outcomes analysed with respect to screen outcomes included the infant’s gender, low birth 
weight infants, neonatal admission and separation from the mother after delivery. None of the 
variables tested yielded statistically significant (p value <0.05) associations with screen 
positive outcomes. (Tables 6.7, 6.8, 6.9 ) 
 
 
Table 6.7 Associated  sociodemographic variables 
 
Variable 
Screen 
positive 
N (%) 
Screen 
negative 
N (%) 
Fisher’s  
exact 
p value 
Pearson’s  
chi square 
p value 
Age  
   18-19 (adolescent mother) 
   20-34 
   35-43 (advanced maternal 
age) 
 
1 (2.1%) 
44 (91.7%) 
3 (6.3%) 
 
8 (6.2%) 
100 (76.9%) 
22 (16.9%) 
 
0.45 
 
 
0.09 
 
Race    
 
 
0.29 
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   Black 
   Coloured 
   Asian 
   White 
 34 (70.8%) 
11 (22.9%) 
2 (4.2%) 
1 (2.1%) 
102 (78.5%) 
19 (14.6%) 
5 (3.8%) 
4 (3.1%) 
 
 
0.61 
0.59 
 
0.19 
Nationality 
   South African 
   Foreign national 
 
31 (64.6%) 
17 (35.4%) 
 
87 (66.9%) 
43 (33.1%) 
 0.77 
Level of education  - grade 12 
   Yes 
   No 
 
33 (68.8%) 
15 (31.3%) 
 
91 (70.0%) 
39 (30.0%) 
 0.87 
Employment status 
   Employed 
   Unemployed 
 
20 (41.7%) 
28 (58.3%) 
 
55 (42.3%) 
75 (57.7%) 
 0.94 
Household monthly Income 
   Less than R2000  
 
17 (35.4%) 
 
45 (34.6%) 
  
0.92 
Marital status 
    Married 
    Unmarried 
 
17 (35.4%) 
  31 (64.6%) 
 
44 (33.8%) 
86 (66.2%) 
 0.85 
Residence post delivery    
   House/flat 
   Informal settlement  
 
42 (87.5%) 
6 (12.5%) 
 
116 (89.2%) 
14 (10.8%) 
 0.75 
Support post delivery 
   Yes 
   No  
 
48 (100.0%) 
0 
 
124 (95.4%) 
6 (4.6%) 
0.15  
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Table 6.8 Associated  antenatal and intrapartum variables 
 
  
 
Variable 
Screen 
positive 
N (%) 
Screen 
negative 
N (%) 
Fisher’s  
exact 
p value 
Pearson’s  
chi square 
p value 
Pregnancy Intention 
   Planned 
   Unplanned 
 
24 (50.0%) 
24 (50.0%) 
 
61 (46.9%) 
69 (53.1%) 
 0.72 
Parity 
   Primiparous 
   Multiparous 
 
15 (31.3%) 
33 (68.8%) 
 
45 (34.6%) 
85 (65.4%) 
  
0.67 
Pregnancy Type 
   Singleton 
   Multiple 
 
47 (97.9%) 
1 (2.1%) 
 
127 (97.7%) 
3 (2.3%) 
0.71  
Preterm delivery 
   Yes 
   No 
 
9 (18.8%) 
39 (81.3%) 
 
27 (20.8%) 
103 (79.2%) 
 0.77 
co-morbid conditions 
  Medical 
   Obstetric 
   None 
 
2 (4.2%) 
4 (8.3%) 
42 (87.6%) 
 
7 (5.3%) 
17 (13.0%) 
107 (81.7%) 
 0.41 
HIV infection 
  Yes 
   No 
 
4 (8.3%) 
44 (91.7%) 
 
22 (16.9%) 
108 (83.1%) 
0.23  
Psychiatric co-morbidities  
   Pre existing psychiatric illness 
   History of PPD 
   Family history 
 
1 (2.1%) 
0 
1(2.1%) 
 
0 
1(0.8%) 
1(0.8%) 
0.31  
Induction of labour  
  Yes 
   No 
 
2 (4.2%) 
46 (95.8%) 
 
6 (4.6%) 
124 (95.4%) 
0.63  
Prolonged labour   
  Yes 
   No 
 
7 (23.3%) 
23 (76.7%) 
 
16 (18.2%) 
72 (81.8%) 
 0.54 
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Table 6.9 Associated  Neonatal outcomes 
 
Variable 
Screen positive 
N (%) 
Screen negative 
N (%) 
Fisher’s  
exact 
p value 
Pearson’s  
chi square 
p value 
Support in labour  
   Yes 
   No 
 
15 (35.7%) 
27 (64.3%) 
 
27 (25.7%) 
78 (74.3%) 
 0.22 
Analgesia in 
labour  
   Yes 
   No 
 
17 (40.5%) 
25 (59.5%) 
 
28 (26.9%) 
76 (73.1%) 
 0.11 
Perineal tears 
Second degree 
tear 
episiotomy 
 
1 (2.1%) 
6 (12.5%) 
 
7 (5.4%) 
20 (15.4%) 
 0.14 
 
Variable 
Screen positive 
N (%) 
Screen negative 
N (%) 
Fisher’s  
exact 
p value 
Pearson’s  
chi square 
p value 
Infants gender 
   Male 
   Female 
 
25 (52.1%) 
23 (47.9%) 
 
71 (54.6%) 
59 (45.4%) 
 0.76 
Low birth weight 
   Yes  
   No  
 
11 (22.9%) 
37 (77.1%) 
 
19 (14.6%) 
111 (85.4%) 
 0.19 
Neonatal 
admission 
   Yes 
   No 
 
8 (16.7%) 
40 (83.3%) 
 
17 (13.1%) 
113 (86.9%) 
 0.37 
Separation from 
mother  
   Yes  
   No  
 
7 (14.6%) 
41 (85.4%) 
 
 
17 (13.1%) 
113 (86.9%) 
 0.79 
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7. Discussion 
7.1 Objective 1 
 To determine the proportion of women who delivered at RMMCH who are at risk of PPD 
using the EPDS at six weeks postnatally 
 
7.1.1 Screening 
An asymptomatic postnatal population that comprised of both low risk and high risk obstetric  
patients was screened using a validated, inexpensive and acceptable instrument to detect  
a treatable condition which is of significant public health concern. A considerable proportion 
(43.8%) of patients exhibited symptoms of major and minor depression. Twenty-seven 
percent of the postnatal sample screened positive for probable major depression in the 
postpartum period. Thoughts of deliberate self-harm were frequent, occurring in 41.7% of 
participants that screened positive for PPD. The literature varies in terms of cut off scores 
used to indicate positivity on the EPDS. The threshold score of 13 or greater used in this study 
was based on the cut off score validated by the original authors and the recommendations of a 
large systematic review.61,64 The value of the EPDS in resource restricted settings lies in its 
high NPV calculated at 93.1% at a threshold score of 12 or13.23,61 
 
Since the EPDS is a screening instrument and not a diagnostic tool the screen positive  
rate cannot be equated to prevalence but may be considered an estimate of prevalence  
in the population studied. The prevalence estimates from fifty-nine studies on PPD were 
included in a meta-analysis conducted by O’ Hara and Swain. A number of these studies used 
self-report measures including the EPDS, which was used in twelve studies to estimate the 
prevalence of PPD in various contexts. The average prevalence rate of non-psychotic PPD 
was found to be 13%.22 In our study the EPDS was used to screen an ethnically diverse, urban 
postnatal sample and resulted in a far higher estimate of PPD prevalence (27%) compared to 
the average prevalence of 13% determined by O’Hara and Swain.22  
 
When compared specifically to other screening studies for PPD conducted in South Africa, 
the proportion of patients that screened positive in this study is higher than the 16.4% screen 
positive rate found amongst mothers who delivered in 1990 in the socioeconomically 
deprived neighbouring urban settlement of Soweto, Johannesburg.47 The Pitt depression 
questionnaire was used to screen participants at six months postnatally in that study. The 
variability in findings may be due to the different assessment methods employed and the 
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different periods postpartum at which participants were screened. HIV infected women were 
screened for PPD within the first year after delivery using the EPDS in the Nkangala district 
in rural South Africa. Overall 45.1% of this population scored above a threshold of 14.  
Despite a higher threshold score used to indicate probable depression in that study, the 
proportion of screen positive participants far exceed  the findings in our study. This may be 
attributed to the significant association between the stigma of HIV infection and the 
experience of discrimination with the development of PPD as demonstrated by the authors.66 
The rate of HIV infection in our study was 14.5%, less than half the rate of 32.5% in the study 
in Nkangala.66 Over half of the HIV infected patients on our study did not have a documented 
CD4 count on their antenatal record. It appears that in the majority of cases the results were 
not followed up. The opportunity to perform additional investigations for the patients with 
low CD4 counts and prescribe prophylactic co-trimoxazole and isoniazide antenatally was 
therefore missed.  
 
The study conducted by Lawrie et al, in which the EPDS was validated for use in urban  
 South Africa, has the most comparable results to our study. They reported a 24.5% incidence 
of PPD in their study conducted at RMMCH in 1998.67 Interestingly, the risk of PPD appears 
to be similar in the communities attending RMMCH almost 20 years later. 
 
7.1.2 Referral to psychiatric services 
All patients approached at recruitment and contacted at follow-up agreed to participate in the 
study. There were no refusals amongst participants implying that mothers were comfortable 
with being screened for PPD. However, more than half of all participants that screened 
positive and were referred for formal psychiatric evaluation declined referral, despite being 
offered sessions at their convenience at RMMCH. The main reason given by the majority of 
participants was that they felt they had adequate social support. This reinforces the role of 
social support in moderating the impact of depressive symptoms.40 However patient-centred 
barriers including social stigma, cost implications, time constraints and childminding during 
consultations may to varying degrees influence patients’ decisions and compliance.18All 
participants that were referred to psychiatry at the follow-up interview due to infant demise 
accepted referral.  
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7.2 Objectives 2 and 3  
To analyse sociodemographic, medical and obstetric data with respect to outcomes and to 
compare screen positive to screen negative patients and comment on correlations between 
possible predisposing factors and outcomes. 
 
7.2.1 Characteristics of the screen positive population  
The mean age of screen positive participants was 26.6 (SD ± 5.2) years, with a range 18 to 42 
years. This is comparable to the mean age of participants in the study sample [27.5 (SD ± 5.9) 
years] as well as the screen negative population [27.8 (SD ± 6.3) years]. Over a third (36.7%) 
of the total coloured population screened were found to be at risk of PPD. This exceeded the 
proportion of Asian (28.6%), black (25%) and white (20%) patients screened who had a 
positive result. Participants were mainly South African (64.5%) owing to the larger 
component of South African nationals in the population screened. However, a greater 
proportion of foreign nationals (28.3%) compared to South Africans (26.2%) were found to be 
at risk of PPD at screening. Married participants comprised 35.4% of the screen positive 
group. Paradoxically, all patients that reported having no support structures in the puerperium 
screened negative for PPD while all screen positive participants reported having social 
support at recruitment. A possible explanation is that mothers not expecting support were 
psychologically motivated and equipped to cope independently while women that experienced 
depressive symptoms may have received less support than expected.  
 
Owing to the small sample size, very few patients screened for PPD had a personal or family 
history of psychiatric illness. One patient with a history of depression in a first degree relative 
and one patient with a current psychiatric diagnosis screened positive for PPD. The small 
sample size however precludes a definitive deduction from these findings.   
 
7.2.2 Sociodemographic variables 
The exclusion of minors diminished the true adolescent pregnancy rate in this study. 
Examining the association of young maternal age with the risk of developing PPD is 
imperative given the vulnerability of adolescent mothers to develop mental health problems.74 
Minors excluded constitute 1.4% of the randomly selected sample. When factored into 
analyses, the true adolescent pregnancy rate for this study sample is calculated at 6.5%. This 
is comparable to the teenage pregnancy rate of 7.2% at RMMCH for the period 2014 to 2015 
as well as to average national figures of 5.2% in 2014.75 Statistical tests demonstrate no 
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significant association between adolescent mothers (excluding minors) and the development 
of PPD in this study.  
 
Poverty was identified as a trigger of PPD in mothers from a low socioeconomic district in 
the North West province of South Africa.76 Unemployment and low household income were 
examined in our study but a significant correlation between these factors with the risk of  
developing PPD did not emerge from statistical analyses.  
 
Maternal age, marital status and level of education were not significantly associated with  
screen positive outcomes in this study. This is compatible with the findings of a large  
meta- analysis that found these sociodemographic variables not to be significant predictors of 
PPD.22 The considerable foreign national component (33.0%) of this cohort was tested against 
screen positive outcomes but yielded no statistically significant association to strengthen the 
literature that suggests that immigrant status is associated with PPD as a consequence of  
acculturation stress.1 
 
7.2.3 Medical and obstetric variables 
Depressed mood was found to be common amongst HIV infected mothers in rural South 
Africa. However HIV infected participants in this study were not found to be at an increased 
risk of developing PPD. 66 Contrary to the findings of the meta-analysis by O’Hara and Swain 
that previous psychopathology is a powerful predictor of PPD, the one patient in this study 
that reported previous PPD scored well below the threshold score at screening.22 However, no 
inferences can be drawn from this isolated finding due the small sample size. 
 
Consistent with the findings of a large meta-analysis, primiparous mothers were not found to 
be at a greater risk of developing PPD in this study.22 The evidence from local and 
international studies support that unintended and unwanted pregnancies contribute to the 
development of PPD.46,75 However, no significant association between unplanned pregnancies 
and screen positive outcomes were demonstrated in this study population. One baby was 
unwanted following delivery and the mother pursued avenues to have the baby adopted. This 
participant screened positive for PPD. Obstetric complications may predispose to the 
development of PPD.42 There was one patient in our study who was classified as a ‘near-miss’ 
as a result of haemorrhage at caesarean section necessitating an emergency hysterectomy. 
Despite this significant peripartum complication, this patient screened negative for PPD. 
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7.2.4 Perinatal events 
The mode of delivery was tested against screen outcomes and the results of this study support 
the findings of Sword et al that mode of delivery does not significantly influence the risk of 
developing PPD.21 The experience of childbirth may well have been unpleasant for a 
considerable proportion of mothers who received no analgesia and were not accompanied by a 
support person in labour. These variables however did not significantly impact screen positive 
outcomes.  
 
According to the 2014 WHO low birth weight policy brief, the majority of low birth weight 
deliveries occur in low and middle-income countries. The rates of pre-term labour (21.5%) 
and small for gestational age infants at term (19.1%) in this study exceed the WHO regional 
estimates for sub-Saharan Africa.77 
 
There is a cultural preference and pressure on women to bear male infants in many low and 
middle income countries.78 The infant’s gender was not significantly associated with 
screening positive for PPD in our study. Mothers of premature infants and infants admitted to 
the neonatal intensive care unit are more likely to experience PPD with depressive 
symptomology being more pronounced in this subgroup.43 This study however did not 
demonstrate a statistically significant association between preterm delivery or neonatal 
admission and the development of probable major depression.  
 
 7.2.5 Association between possible predisposing factors and outcomes. 
Sociodemographic, medical, obstetric and perinatal variables were analysed with respect to 
screen outcomes. All variables tested yielded no significant association with screening 
positive for PPD. No reliable predictors of outcome are therefore implicated by these findings. 
The success of selective screening for PPD would depend on identifying high risk patients to 
be screened. The complex aetiology of PPD, the considerable number of potential risk factors 
that exist and the inconsistent association between these factors and established disease make 
it difficult to reliably recognise high risk patients. Selective screening may therefore result in 
a number of cases going undetected.  The morbidity and complications associated with PPD 
emphasize the importance of “ruling in” as opposed to “ruling out” the condition by 
screening. Universal screening would offer a distinct advantage in detecting patients who are 
at risk of developing PPD. 
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7.3 Generalisability of findings 
Approximately two-thirds of the participants enrolled into this study completed grade twelve. 
The exclusion of non-English speaking patients may have contributed toward a better 
educated cohort being recruited. Despite high levels of education amongst participants, this 
urban population is socioeconomically disadvantaged with almost two-thirds being 
unemployed and 74.5% arising from households with a monthly income below five thousand 
rands. One third of the study sample comprised foreign nationals. All immigrants were from 
developing countries, mainly in sub-Saharan Africa. The findings of this study are applicable 
but not necessarily generalisable to low socioeconomic urban populations in the developing 
world.  
 
7.4 Limitations 
This study is limited by its small numbers and additional 9.0% loss to follow up. No 
significant association between potential explanatory variables and screen positive outcomes 
were demonstrated in this study which may be attributed to the small sample size. Non-
English speaking patients were excluded from the study. This comprised 4.1% of the initial 
sample selected. It is uncertain whether the results are impacted significantly as a result of this 
exclusion. The exclusion of minors may have undermined the true impact of adolescent 
motherhood on the development of PPD. Important variables that constitute recognised 
predisposing factors to screen positive outcomes which were not assessed in this study 
include maternal obesity, marital satisfaction scores, intimate partner violence and the use of 
injectable progestogens immediately postpartum.22,40,41,68  
 
7.5 Recommendations 
Adequately powered studies examining factors that may be associated with the risk of 
developing PPD in a South African setting are recommended. Further research to evaluate the 
feasibility and practical elements of screening for PPD in South Africa is warranted. This 
includes identifying the ideal screening instrument for use in both rural and urban settlements 
and the timing and opportunities for screening. The postnatal follow up occurs at primary 
health care level and it is our recommendation that greater detail and emphasis on PPD be 
included in the next maternal care guidelines. There is a high reliance on public sector health 
care in South Africa and a number of barriers exist to patients accessing adequate care. 
Studies evaluating established and potential mental health referral and follow up networks as 
well as examining the barriers to psychiatric care is recommended.  
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8. Conclusion 
The DSM prescribes that symptoms of major depression should occur within four weeks of 
childbirth to establish the diagnosis of PPD. This study has demonstrated that postpartum 
depressive symptomology is common in the general obstetric population beyond 4 weeks 
postnatally supporting the literature that allows for the diagnosis of PPD beyond this time 
frame. The condition is too often underdiagnosed raising the importance of clinical acumen 
on the part of healthcare providers in recognising symptoms and detecting patients at risk of 
PPD in the puerperium and the months that follow. The aetiology and precipitants of PPD are 
multifactorial. No significant association between potential predisposing factors and screening 
positive for probable major depression in the postpartum period were established in this study. 
It can therefore be challenging to reliably identify patients antenatally or immediately 
postpartum who at risk of developing PPD. These findings are support the rationale of 
universal screening for PPD in South Africa.  
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Appendix A  
 
Major Depressive Disorder - DSM V 
Diagnostic Criteria 
A. Five (or more) of the following symptoms have been present during the same 2-week 
period and represent a change from previous functioning: at least one of the symptoms 
is either (1) depressed mood or (2) loss of interest or pleasure. 
Note: Do not include symptoms that are clearly attributable to another medical condition. 
 
1. Depressed mood most of the day, nearly every day, as indicated by either subjective 
    report (e.g., feels sad, empty, hopeless) or observation made by others (e.g., appears      
    tearful). 
2. Markedly diminished interest or pleasure in all, or almost all, activities most of the 
    day, nearly every day (as indicated by either subjective account or observation). 
3. Significant weight loss when not dieting or weight gain (e.g., a change of more than 
    5% of body weight in a month), or decrease or increase in appetite nearly every day. 
4. Insomnia or hypersomnia nearly every day. 
5. Psychomotor agitation or retardation nearly every day (observable by others, not 
    merely subjective feelings of restlessness or being slowed down). 
6. Fatigue or loss of energy nearly every day. 
7. Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) 
    nearly every day (not merely self-reproach or guilt about being sick). 
8. Diminished ability to think or concentrate, or indecisiveness, nearly every day (either 
    by subjective account or as observed by others). 
9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without 
    a specific plan, or a suicide attempt or a specific plan for committing suicide. 
 
B. The symptoms cause clinically significant distress or impairment in social, occupational or          
     other important areas of functioning. 
C. The episode is not attributable to the physiological effects of a substance or to another 
     medical condition. 
 
Note: Criteria A-C represent a major depressive episode. 
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Note: Responses to a significant loss (e.g., bereavement, financial ruin, losses from a natural 
disaster, a serious medical illness or disability) may include the feelings of intense sadness, 
rumination about the loss, insomnia, poor appetite, and weight loss noted in Criterion A, 
which may resemble a depressive episode. Although such symptoms may be understandable 
or considered appropriate to the loss, the presence of a major depressive episode in addition to 
the normal response to a significant loss should also be carefully considered. This decision 
inevitably requires the exercise of clinical judgment based on the individual’s history and the 
cultural norms for the expression of distress in the context of loss. 
 
D. The occurrence of the major depressive episode is not better explained by schizoaffective 
disorder, schizophrenia, schizophreniform disorder, delusional disorder, or other specified and 
unspecified schizophrenia spectrum and other psychotic disorders. 
 
E. There has never been a manic episode or a hypomanic episode. 
 
With peripartum onset: This specifier can be applied to the current or, if full criteria are not 
currently met for a major depressive episode, most recent episode of major depression if onset 
of mood symptoms occurs during pregnancy or in the 4 weeks following delivery. 
 
Note: Mood episodes can have their onset either during pregnancy or postpartum. Although 
the estimates differ according to the period of follow-up after delivery, between 3% and 6% 
of women will experience the onset of a major depressive episode during pregnancy or in the 
weeks or months following delivery. Fifty percent of “postpartum” major depressive episodes 
actually begin prior to delivery. Thus, these episodes are referred to collectively as peripartum 
episodes. Women with peripartum major depressive episodes often have severe anxiety and 
even panic attacks. Prospective studies have demonstrated that mood and anxiety symptoms 
during pregnancy, as well as the “baby blues,” increase the risk for a postpartum major 
depressive episode. 
 
Peripartum-onset mood episodes can present either with or without psychotic features. 
Infanticide is most often associated with postpartum psychotic episodes that are characterized 
by command hallucinations to kill the infant or delusions that the infant is possessed, but 
psychotic symptoms can also occur in severe postpartum mood episodes without such specific 
delusions or hallucinations. Postpartum mood (major depressive or manic) episodes with 
psychotic features appear to occur in from 1 in 500 to 1 in 1,000 deliveries and may be more 
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common in primiparous women. The risk of postpartum episodes with psychotic features is 
particularly increased for women with prior postpartum mood episodes but is also elevated for 
those with a prior history of a depressive or bipolar disorder (especially once a woman has 
had a postpartum episode with psychotic features, the risk of recurrence with each subsequent 
delivery is between 30% and 50%. Postpartum episodes must be differentiated from delirium 
occurring in the postpartum period, which is distinguished by a fluctuating level of awareness 
or attention. The postpartum period is unique with respect to the degree of neuroendocrine 
alterations and psychosocial adjustments, the potential impact of breast-feeding on treatment 
planning, and the long-term implications of a history of postpartum mood disorder on 
subsequent family planning. 
 
Source: American Psychiatric Association: Diagnostic and Statistical Manual of Mental    
             Disorders. 5th ed. Arlington, VA, American Psychiatric Association, 2013.  
             pp 160-187. 
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Appendix B 
 
Edinburgh Postnatal Depression Scale (EPDS) 
 
In the past 7 days: 
A. I have been able to laugh and see the funny side of things        
0. As much as I always could                                                                                  
1. Not quite so much now                                                                                     
2. Definitely not so much now                                                                             
3. Not at all                                                                                                     
 
B. I have looked forward with enjoyment to things                              
0. As much as I ever did                                                                                     
1. Rather less than I used to                                                                             
2. Definitely less than I used to                                                       
3. Hardly at all                                                    
  
*C. I have blamed myself unnecessarily when things went wrong      
3. Yes, most of the time                                                       
2. Yes, quite often 
1. Not very often 
0. No, not at all                                                                                                         
 
D. I have been anxious or worried for no good reason                           
0. No, not at all                                                                    
1. Hardly ever                             
2. Yes, sometimes                              
3. Yes, very often                              
 
*E. I have felt scared or panicky for no very good reason                   
3. Yes, quite a lot                                                       
2. Yes, sometimes                            
1. No, not much                            
0. No, not at all                                                                                            
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* F. Things have been getting on top of me 
3. Yes, most of the time I haven’t been able to cope at all 
2. Yes, sometimes I haven’t been coping as well as usual 
1. No, most of the time I have coped quite well 
0. No, I have been coping as well as ever 
  
*G. I have been so unhappy that I have had difficulty sleeping       
3. Yes, most of the time           
2. Yes, sometimes 
1. Not very often          
0. No, not at all  
 
*H. I have felt sad or miserable 
3. Yes, most of the time 
2. Yes, some of the time 
1. Not very often 
0. No, never  
 
* I. I have been so unhappy that I have been crying 
3. Yes, most of the time 
2. Yes, quite often 
1. Only occasionally 
0. No, never 
 
* J. The thought of harming myself has occurred to me 
3. Yes, quite often 
2. Sometimes 
1. Hardly ever 
0. Never 
 
Supplementary question - Have you ever thought of harming your baby? 
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Scoring 
 
QUESTIONS A, B, & D 
are scored with top box scored as 0 and the bottom box scored as 3. 
QUESTIONS C, E - J (marked with an *) 
are reverse scored, with the top box scored as a 3 and the bottom box scored as 0. 
Maximum score: 30 
At risk for Depression: 13 or greater 
 
Users may reproduce the scale without further permission, providing they respect copyright 
by quoting the names of the authors, the title, and the source of the paper in all reproduced 
copies. 
Source: 
 Cox, J.L., Holden, J.M. & Sagovsky, R. 1987. Detection of postnatal depression: 
development of the 10-item Edinburgh postnatal depression scale. Br J Psychiatry.,150:782-
786. 
Wisner, K. L.,Parry, B. L. & Piontek, C. M. 2002. Postpartum Depression. N Engl J Med., 
347(3):194-199. 
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